4-89247812-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198281.3(GPRIN3):c.2299G>A(p.Val767Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,332 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198281.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPRIN3 | NM_198281.3 | c.2299G>A | p.Val767Ile | missense_variant | 2/2 | ENST00000609438.2 | NP_938022.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPRIN3 | ENST00000609438.2 | c.2299G>A | p.Val767Ile | missense_variant | 2/2 | 2 | NM_198281.3 | ENSP00000476603 | P1 | |
GPRIN3 | ENST00000333209.4 | c.2299G>A | p.Val767Ile | missense_variant | 1/1 | ENSP00000328672 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251000Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135630
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461214Hom.: 0 Cov.: 34 AF XY: 0.0000138 AC XY: 10AN XY: 726842
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.2299G>A (p.V767I) alteration is located in exon 2 (coding exon 1) of the GPRIN3 gene. This alteration results from a G to A substitution at nucleotide position 2299, causing the valine (V) at amino acid position 767 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at